Aldeyra Allergic Conjunctivitis Drug Has Good Prospects With Phase III Results

Warming Temperatures Expand Market Potential

 
• By Alaric DeArment
  
Eye
ALDEYRA ANNOUNCES POSITIVE DATA IN PHASE III ALLERGIC CONJUNCTIVITIS STUDY • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D